Stockholders' Equity

9 Months Ended

Dec. 31, 2022

Stockholders' Equity Note [Abstract]

Stockholders' Equity

Stockholders' Equity

Stock Repurchase Program. The Company's Board of Directors has approved various authorizations under the Company's stock repurchase program to repurchase shares of its common stock, including a July 27, 2022 approval to increase its stock repurchase authorization by $1,200,000, (collectively, the stock repurchase program). The stock repurchase program does not oblige the Company to acquire any amount of common stock and may be suspended at any time at the Company's discretion. As of December 31, 2022, the aggregate remaining approved amount under the stock repurchase program is $1,459,145.

Stock repurchase activity under the Company's stock repurchase program, was as follows:

	Nine Months Ended December 31,
	2022		2021
Total number of shares repurchased*	685,075		735,976
Weighted average price paid per share	$	284.44	$	362.36
Dollar value of shares repurchased**	$	194,862	$	266,684

*All share repurchases were made pursuant to our publicly announced stock repurchase program in open-market transactions.

** May not calculate on rounded dollars.

Accumulated Other Comprehensive Loss. The components within AOCL, net of tax, recorded in the condensed consolidated balance sheets are as follows:

	December 31, 2022		March 31, 2022
Unrealized loss on cash flow hedges	$	(237)	$	—
Cumulative foreign currency translation loss	(40,039)		(24,955)
Total	$	(40,276)	$	(24,955)